Journey Medical Stock Forecast

Sell candidate since Jun 16, 2026

The Journey Medical Corporation stock price fell by -3.63% on the last day (Tuesday, 16th Jun 2026) from $6.34 to $6.11. During the last trading day the stock fluctuated 6.08% from a day low at $6.09 to a day high of $6.46. The price has risen in 6 of the last 10 days and is up by 1.5% over the past 2 weeks. Volume has increased on the last day by 344 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 501 thousand shares were bought and sold for approximately $3.06 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.12% during the next 3 months and, with a 90% probability hold a price between $5.20 and $7.05 at the end of this 3-month period.

DERM Signals & Forecast

The Journey Medical Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.19. On a fall, the stock will find some support from the long-term average at approximately $5.80. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -3.78%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Journey Medical Corporation stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.19 and $4.95. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Journey Medical Corporation finds support just below today's level at $5.19. If this is broken, then the next support from accumulated volume will be at $4.95 and $4.78.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.370 (6.08%) between high and low. For the last week, the stock has had daily average volatility of 4.12%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DERM) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Journey Medical Corporation to open at $6.22, and during the day (based on 14 day Average True Range), to move between $5.96 and $6.26, which gives a possible trading interval of +/-$0.303 (+/-5.08%) up or down from last closing price. If Journey Medical Corporation takes out the full calculated possible swing range there will be an estimated 5.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.35 (3.93%) than the support at $5.19 (15.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Journey Medical Corporation stock A Buy?

The Journey Medical Corporation stock holds several negative signals and despite the positive trend, we believe Journey Medical Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.678 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $6.22 ( 1.80%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk